[Hospital-acquired pneumonias]

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Pulmonology

Background:

• Nosocomial infections, particularly hospital-acquired pneumonia (HAP), represent a significant challenge in healthcare settings.
• HAP is a leading cause of mortality among hospital-acquired infections, often driven by antibiotic-resistant bacterial strains.
• Diagnostic challenges and the complexity of management, including empirical antibiotic therapy, contribute to unfavorable prognoses.

Purpose of the Study:

• To highlight the critical issues surrounding hospital-acquired pneumonia (HAP).
• To emphasize the challenges in diagnosing the etiology of HAP.
• To discuss the complexities of HAP management and its impact on morbidity and mortality.

Main Methods:

• Review of current literature on hospital-acquired pneumonia (HAP).
• Analysis of diagnostic difficulties and treatment strategies.
• Examination of factors influencing HAP prognosis and complications.

Main Results:

• Hospital-acquired pneumonia (HAP) is a frequent and severe nosocomial infection.
• Rising antibiotic resistance in hospital bacteria complicates treatment efficacy.
• Delayed or inappropriate management increases the risk of local and extrapulmonary complications, raising morbidity and mortality.

Conclusions:

• Effective management of hospital-acquired pneumonia (HAP) hinges on timely and appropriate empirical antibiotic treatment.
• The prognosis for HAP is often poor, particularly in vulnerable patient groups like the elderly or those with multiple comorbidities.
• Addressing antibiotic resistance and improving diagnostic accuracy are essential for better HAP outcomes.